Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 408 news and 218 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Blogs

Recent blog posts on this topic.

EU antitrust officials probe parallel trademore

Parallel trade in Europe has attracted the gimlet eye of antitrust regulators. EU investigators launched a probe into...

Pennsylvania still trying get a slice of J&J Risperdal payoutsmore

An appeal being heard today on a case seen as the precursor to the mountains of litigation over Johnson & Johnson's...

Top 10 Best-selling Cancer Drugs in 2011more

Oncology drugs are hot. Scratch beneath the surface of most major drugmakers, and you'll find a host of them in various...

UK Pharma Trade Group May Restrict Samplesmore

In a bid to tighten its voluntary code of practice, the Association of the British Pharmaceutical Industry has proposed...

Senate probes ties among narcoticsmakers, pain organizationsmore

The pharma industry's promotional practices are under scrutiny once again. This time, the spotlighted products are...

Pharmalot… Pharmalittle… Good Morningmore

Good morning, folks. How are you today? Some gloomy clouds are hovering over the Pharmalot corporate campus, but these...

Pharmalot… Pharmalittle… Good Morningmore

Good morning, everyone, and nice to see you again. We hope the weekend was refreshing. As for us, we are back from a...

Pfizer's DTC ad spending dwarfs rivalsmore

Last week, Advertising Age celebrated a big direct-to-consumer ad campaign that's in the works for Purdue Pharma's new...

Pfizer eyes ad agency work for cost-cuttingmore

After a series of ad agency shuffles over the past several years, Pfizer ($PFE) is conducting an overall review of its...

U.S. drug spending up, thanks to new drug launchesmore

The good news: New drugs do push up drug spending. At least that was the case in 2011, when U.S. spending on...

Oh, A Wise Guy, Eh? Then Stoogesta Is For Youmore

“Ever dropped a bell on a nun, ripped the armpit hair off an old man or stuffed a live lobster down a loved one’s...

France's drug spending will shrink for first time, IMS saysmore

Call it the French retrench. After two years of no growth, the drug market in France is projected to shrink 1% to 2%,...

Dr. Reddy's nears launch of Fujifilm venture, CFO saysmore

After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint...

Valeant nabs Russia's Natur Produkt for $175M-plusmore

We sound like a broken record when it comes to Valeant Pharmaceuticals ($VRX): The Canadian drugmaker has made yet...

Takeda scouts for M&A in India, plots Chinese growthmore

India and China are on most expansion-minded drugmakers' shopping lists. So, it's not a huge surprise that top Japanese...

Dr. Reddy's eyes acquisitions in Russiamore

India's Dr. Reddy's Laboratories plans to go shopping in Russia. The generics specialist wants to expand its portfolio...

Pfizer Cuts Jobs In Germany: Is It Payback?more

There is certainly nothing surprising that Pfizer or any other large drugmaker is planning to cut jobs.

J&J's Scios to plead guilty, pay $85M in Natrecor casemore

Johnson & Johnson's ($JNJ) legion of legal problems is one less strong. The company agreed to pay $85 million and...

Pharmalot… Pharmalittle… Good Morningmore

Top of the morning to you. We have just returned from one of the local schoolhouses, where we have deposited a sleepy...

Aspen Pharmacare eyes another $800M in M&Amore

South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion...

Newer Drugs Must Be Better, Right?more

Is this surprising? A new study finds that 39 percent of the public mistakenly believes that the FDA approves only...

Dems Press FTC On Express Scripts-Medco Dealmore

Three Democratic members of the US House are pressing the US Federal Trade Commission to conduct an in-depth analysis...

J&J investor demands that CEO give up millions in paymore

Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is the highest-paid Big Pharma chief, no question. His $28.

Biogen takes European MS marketing in-house with JV buyoutsmore

Biogen Idec ($BIIB) is taking its multiple sclerosis marketing in house. The Massachusetts-based company has bought out...

Lilly in partnership talks with Turkey's MN Pharmamore

Emerging markets continue to beckon Big Pharma. Eli Lilly ($LLY) is in partnership talks with Turkey's Mustafa Nevzat...

Top Sources: Drug Marketing

  • medicinesocialjustice.blogspot.com
  • News
  • blogs.nature.com
  • carlatpsychiatry.blogspot.com
  • doseofdigital.com
  • drugreptoys.blogspot.com
  • CNBC
  • eyeonfda.com
  • pharmamkting.blogspot.com
  • drugchannels.net

Most Active Users in this Topic

see all contributors in Drug Marketing

Featured White Papers

Post a Job

Jobs in this Topic

Account Supervisor Shopper Marketing Advantage Sales & Marketing | Englewood Cliffs, NJ
Posted: May 18
Pharma Senior Finance Effectiveness PwC | Hartford, CT
Posted: May 17
Delivery Driver-AD Homesmart | Raleigh, NC
Posted: May 23
Digital Pharma Marketing - Advertising Roles T Scott International | New York, NY
Posted: May 11

Report comment contains invalid characters. ()
cancel
Search Cancel